Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$154.1M
+16.4% from 2023
Prescriptions
5,564
$27,704.19 per claim
Patients
470
300 prescribers
Total spending, 2024
$154.5M
$328,086.56 per patient
Medicare prescription drug plans paid $154.1M for Evrysdi in 2024, for 5,564 prescriptions and refills to 470 patients (up 16.4% from 2023). The average cost per claim was $27,704.19.
California had the highest Medicare cost for Evrysdi in 2024: $16.6M for 589 claims, followed by Ohio ($11.3M).
Mario A Saporta, neurology in Miami, FL, had the highest Medicare cost for Evrysdi in 2024: 108 claims costing $3.2M.
Evrysdi is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mario A Saporta Miami, FL | Neurology | 108 | Under 11 | $3.2M |
| Bakri H Elsheikh Columbus, OH | Neurology | 115 | Under 11 | $3.0M |
| Stacy E Dixon Aurora, CO |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 270 | 4,680 | 416 | $120.8M |
| 2023 | 275 | 4,833 | 424 | $132.4M |
| 2024 | 300 | 5,564 | 470 | $154.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 97 |
| Under 11 |
| $2.7M |
| Peter I Karachunski Minneapolis, MN | Neurology | 90 | Under 11 | $2.6M |
| Michelle S Gapay Stanford, CA | Nurse Practitioner | 88 | Under 11 | $2.6M |
| Nanette C Joyce Sacramento, CA | Physical Medicine and Rehabilitation | 90 | Under 11 | $2.4M |
| Senda Ajroud-Driss Chicago, IL | Neuropsychiatry | 80 | Under 11 | $2.4M |
| Arun S Varadhachary Saint Louis, MO | Neurology | 86 | Under 11 | $2.3M |
| Doreen T Ho Burlington, MA | Neurology | 71 | Under 11 | $2.0M |
| Jeffrey Rosenfeld Fresno, CA | Neurology | 73 | Under 11 | $1.9M |
| Shafeeq S Ladha Phoenix, AZ | Neurology | 59 | Under 11 | $1.8M |
| Randal C Richardson Saint Paul, MN | Neurology | 62 | Under 11 | $1.8M |
| Brent A Beson Oklahoma City, OK | Neurology | 57 | Under 11 | $1.8M |
| Alan Pestronk Saint Louis, MO | Neurology | 59 | Under 11 | $1.7M |
| Nivedita U Jerath Apopka, FL | Neurology | 65 | Under 11 | $1.7M |
| Hani A Kushlaf Cincinnati, OH | Neurology | 65 | Under 11 | $1.7M |
| Nassim Rad Seattle, WA | Physical Medicine and Rehabilitation | 53 | Under 11 | $1.7M |
| Jin Li Hawthorne, NY | Neurology | 62 | Under 11 | $1.6M |
| Charlotte J Sumner Baltimore, MD | Neurology | 59 | Under 11 | $1.5M |
| Katherine D Mathews Iowa City, IA | Neurology | 54 | Under 11 | $1.4M |
| Sarah M Jones Charlottesville, VA | Neurology | 44 | Under 11 | $1.4M |
| Perry B Shieh Los Angeles, CA | Neurology | 48 | Under 11 | $1.3M |
| Manisha K Korb West Palm Beach, FL | Neuropsychiatry | 49 | Under 11 | $1.3M |
| Prasad V Kanneganti Columbus, OH | Neurology | 46 | Under 11 | $1.2M |
| Edwardo Ramos Cortes San Juan, PR | Physical Medicine and Rehabilitation | 45 | Under 11 | $1.2M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 5,578 | $154.5M |